-
Preclinical Services
- Barriers to Bioavailability
- Binding and Distribution
- Bioanalysis
- Bioavailability and Exposure
- BCS Classification
- CellPort® Drug Transporters
- Custom Services
- Dose Vehicle Assessment
- Ex Vivo Tissue Permeability
- ExpressPlus™
- Formulation Development
- In Situ Organ Perfusion
- Metabolism
- Metabolite ID and Production
- Ocular Models
- Permeability
- Physicochemical
- PK and Biodistribution
- SafetySuite™
- Toxicology
- Biologics
- Medical Devices
- Ocular
ExpressPlus Predesigned Assays
Identify Promising Leads at an Early Stage of Drug Discovery
Our predesigned ExpressPlus™ assays enable companies to profile the ADME properties of their compounds with confidence, knowing that the test systems are under control. We use the same well validated test systems as we do for NDA-enabling studies. Providing high-quality, consistent and reproducible data is our business.
"ADME screening assays with predesigned protocols are remarkably useful for identifying promising drug-like leads at an early stage of drug discovery"
 |
Customization without Compromise |
• No minimum compounds or assays required
• Rapid turnaround time in 5 days or less
• High-quality, reproducible data from extensively validated test systems
• Value-added study report
• Discounts for multiple compounds or assays in a single order
ExpressPlus Assay Services
LogD and Solubility Permeability Transporters Metabolism Enzyme Inhibition Protein Binding Pharmacokinetics
Download ExpressPlus ADME in vitro order form Download ExpressPlus ADME in vivo order form View all assays
We also offer custom model development for each of these assays in addition to an array of other test systems.